The comparison depends on whether bacterial growth persists across defined antibiotic concentrations relative to an untreated control. Growth measurements are assembled into a susceptibility profile, allowing isolates to be characterized by their observed response rather than by assumptions about treatment performance. This phenotype-level information supports comparisons among isolates and helps identify patterns associated with resistance.
A minimum inhibitory concentration provides a concentration-based summary of the antibiotic level associated with inhibition in the assay. Including this value makes susceptibility profiles more informative than a simple growth or no-growth observation, because researchers can compare responses across isolates, examine resistance patterns, and evaluate how candidate drugs perform under defined testing conditions.
The untreated control establishes the growth reference for bacteria that were not exposed to the antimicrobial compound. Researchers can then interpret reduced or persistent growth in exposed samples against that baseline rather than viewing the measurement in isolation. This comparison strengthens the assessment of inhibition and supports reliable construction of a susceptibility profile.
A typical workflow exposes bacterial isolates to defined concentrations of an antibiotic, measures or compares growth, and evaluates the results against an untreated control. The resulting observations are organized into a susceptibility profile, which may include a minimum inhibitory concentration. This sequence connects the experimental exposure directly to an interpretable resistance phenotype.
The method allows researchers to test how bacterial isolates respond to candidate antimicrobial compounds under defined concentration conditions. Comparing growth outcomes and susceptibility profiles can reveal whether a candidate inhibits the isolates being studied. These results support early evaluation of drug performance and help place candidate compounds within broader investigations of treatment failure and resistance.
In clinical biology, screening results can inform antimicrobial selection and help investigate resistance patterns associated with treatment failure. In environmental biology, the same approach supports surveillance of resistance phenotypes and studies of how resistance emerges and spreads. Across both settings, standardized growth comparisons provide evidence for tracking resistance and developing strategies to limit resistant infections.